{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:43:05Z","timestamp":1784641385019,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hebei Medical Science Research Project Plan","award":["20231885"],"award-info":[{"award-number":["20231885"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00380-024-02398-2","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T12:01:55Z","timestamp":1713441715000},"page":"673-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of early administration of sacubitril\/valsartan after coronary artery revascularization in patients with acute myocardial infarction complicated by moderate-to-severe mitral regurgitation: a randomized controlled trial"],"prefix":"10.1007","volume":"39","author":[{"given":"Hongtao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"2398_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.amjcard.2021.07.029","volume":"157","author":"H Sharma","year":"2021","unstructured":"Sharma H, Radhakrishnan A, Nightingale P, Brown S, May J, O\u2019Connor K, Shakeel I, Zia N, Doshi SN, Townend JN, Myerson SG, Kirchhof P, Ludman PF, Adnan Nadir M, Steeds RP (2021) Mitral regurgitation following acute myocardial infarction treated by percutaneous coronary intervention-prevalence, risk factors, and predictors of outcome. Am J Cardiol 157:22\u201332","journal-title":"Am J Cardiol"},{"key":"2398_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.004841","volume":"9","author":"S Nishino","year":"2016","unstructured":"Nishino S, Watanabe N, Kimura T, Enriquez-Sarano M, Nakama T, Furugen M, Koiwaya H, Ashikaga K, Kuriyama N, Shibata Y (2016) The course of ischemic mitral regurgitation in acute myocardial infarction after primary percutaneous coronary intervention: from emergency room to long-term follow-up. Circ Cardiovasc Imaging 9:e004841","journal-title":"Circ Cardiovasc Imaging"},{"key":"2398_CR3","first-page":"1166","volume":"35","author":"Branch of Cardiovascular Physicians, Chinese Medical Doctor Association, China Cardiovascular Health Alliance, The Expert Consensus Working Group on the Prevention and Treatment of Heart Failure After Myocardial Infarction","year":"2020","unstructured":"Branch of Cardiovascular Physicians, Chinese Medical Doctor Association, China Cardiovascular Health Alliance, The Expert Consensus Working Group on the Prevention and Treatment of Heart Failure After Myocardial Infarction (2020) 2020 expert consensus on the prevention and treatment of heart failure after myocardial infarction. Chinese Circulation Journal 35:1166\u20131180","journal-title":"Chinese Circulation Journal"},{"key":"2398_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchf.2019.08.014","volume":"8","author":"P van der Bijl","year":"2020","unstructured":"van der Bijl P, Abou R, Goedemans L, Gersh BJ, Holmes DR Jr, Ajmone Marsan N, Delgado V, Bax JJ (2020) Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era. JACC Heart Fail 8:131\u2013140","journal-title":"JACC Heart Fail"},{"key":"2398_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11897-021-00501-6","volume":"18","author":"A Abboud","year":"2021","unstructured":"Abboud A, Januzzi JL (2021) Reverse cardiac remodeling and ARNI therapy. Curr Heart Fail Rep 18:71-83","journal-title":"Curr Heart Fail Rep"},{"key":"2398_CR6","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","volume":"139","author":"DH Kang","year":"2019","unstructured":"Kang DH, Park SJ, Shin SH, Hong GR, Lee S, Kim MS, Yun SC, Song JM, Park SW, Kim JJ (2019) Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation 139:1354\u20131365","journal-title":"Circulation"},{"key":"2398_CR7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1161\/CIRCULATIONAHA.122.061693","volume":"146","author":"JL Januzzi","year":"2022","unstructured":"Januzzi JL, Omar A, Liu Y, Murphy S, Butler J, Felker GM, Pi\u00f1a IL, Ward J, Solomon S, Contreras J (2022) Association between sacubitril\/valsartan initiation and mitral regurgitation severity in heart failure with reduced ejection fraction: the PROVE-HF Study. Circulation 146:1638\u20131640","journal-title":"Circulation"},{"key":"2398_CR8","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:e895\u2013e1032","journal-title":"Circulation"},{"key":"2398_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray J, Anand IS, Ge J, Lam C, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, D\u00fcngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381:1609\u20131620","journal-title":"N Engl J Med"},{"issue":"37","key":"2398_CR10","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44(37):3627\u20133639","journal-title":"Eur Heart J"},{"key":"2398_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00380-023-02311-3","volume":"39","author":"Y Nishihara","year":"2024","unstructured":"Nishihara Y, Nishimori M, Sawa T, Uemura K, Nagai S, Todo S, Oota E, Odajima S, Takeuchi K, Ichikawa Y, Kintsu M, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Shimizu M, Hirata KI, Tanaka H (2024) Left ventricular reverse remodeling following initiation of sacubitril\/valsartan for heart failure with reduced ejection fraction and low blood pressure. Heart Vessels 39:95\u2013104","journal-title":"Heart Vessels"},{"key":"2398_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.122.060841","volume":"146","author":"R Mehran","year":"2022","unstructured":"Mehran R, Steg PG, Pfeffer MA, Jering K, Claggett B, Lewis EF, Granger C, K\u00f8ber L, Maggioni A, Mann DL, McMurray J, Rouleau JL, Solomon SD, Ducrocq G, Berwanger O, De Pasquale CG, Landmesser U, Petrie M, Leng D, van der Meer P, Lefkowitz M, Zhou Y, Braunwald E (2022) The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial. Circulation 146:1749\u20131757","journal-title":"Circulation"},{"key":"2398_CR13","first-page":"369","volume":"60","author":"HB He","year":"2008","unstructured":"He HB, Yang XZ, Shi MQ, Zeng XW, Wu LM, Li LD (2008) Comparison of cardioprotective effects of salvianolic acid B and benazepril on large myocardial infarction in rats. Pharmacol Rep 60:369\u2013381","journal-title":"Pharmacol Rep"},{"key":"2398_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1470320308353059","volume":"10","author":"K Charan Sahoo","year":"2009","unstructured":"Charan Sahoo K, Arora S, Goyal S, Kishore K, Ray R, Nag TC, Singh Arya D (2009) Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats. J Renin Angiotensin Aldosterone Syst 10:201\u2013209","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2398_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"2398_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","volume":"2","author":"M Ishii","year":"2017","unstructured":"Ishii M, Kaikita K, Sato K, Sueta D, Fujisue K, Arima Y, Oimatsu Y, Mitsuse T, Onoue Y, Araki S, Yamamuro M, Nakamura T, Izumiya Y, Yamamoto E, Kojima S, Kim-Mitsuyama S, Ogawa H, Tsujita K (2017) Cardioprotective effects of LCZ696 (Sacubitril\/Valsartan) after experimental acute myocardial infarction. JACC Basic Transl Sci 2(6):655\u2013668","journal-title":"JACC Basic Transl Sci"},{"key":"2398_CR17","doi-asserted-by":"publisher","first-page":"6032631","DOI":"10.1155\/2019\/6032631","volume":"2019","author":"PC Chang","year":"2019","unstructured":"Chang PC, Lin SF, Chu Y, Wo HT, Lee HL, Huang YC, Wen MS, Chou CC (2019) LCZ696 therapy reduces ventricular tachyarrhythmia inducibility in a myocardial infarction-induced heart failure rat model. Cardiovasc Ther 2019:6032631","journal-title":"Cardiovasc Ther"},{"issue":"19","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","volume":"72","author":"J Torrado","year":"2018","unstructured":"Torrado J, Cain C, Mauro AG, Romeo F, Ockaili R, Chau VQ, Nestler JA, Devarakonda T, Ghosh S, Das A, Salloum FN (2018) Sacubitril\/valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits. J Am Coll Cardiol 72(19):2342\u20132356","journal-title":"J Am Coll Cardiol"},{"key":"2398_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjcard.2020.12.037","volume":"143","author":"ASM Rezq","year":"2021","unstructured":"Rezq ASM, El Nozahi M (2021) Comparison of the efficacy and safety of sacubitril\/valsartan versus ramipril in patients with ST-segment elevation myocardial infarction. Am J Cardiol 143:7\u201313","journal-title":"Am J Cardiol"},{"key":"2398_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.121.054892","volume":"144","author":"KF Docherty","year":"2021","unstructured":"Docherty KF, Campbell RT, Brooksbank K, Dreisbach JG, Forsyth P, Godeseth RL, Hopkins T, Jackson AM, Lee M, McConnachie A, Roditi G, Squire IB, Stanley B, Welsh P, Jhund PS, Petrie MC, McMurray J (2021) Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation 144:199\u2013209","journal-title":"Circulation"},{"key":"2398_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ejhf.2191","volume":"23","author":"KS Jering","year":"2021","unstructured":"Jering KS, Claggett B, Pfeffer MA, Granger C, K\u00f8ber L, Lewis EF, Maggioni AP, Mann D, McMurray J, Rouleau JL, Solomon SD, Steg PG, van der Meer P, Wernsing M, Carter K, Guo W, Zhou Y, Lefkowitz M, Gong J, Wang Y, Merkely B, Macin SM, Shah U, Nicolau JC, Braunwald E (2021) Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics. Eur J Heart Fail 23:1040\u20131048","journal-title":"Eur J Heart Fail"},{"key":"2398_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","volume":"385","author":"MA Pfeffer","year":"2021","unstructured":"Pfeffer MA, Claggett B, Lewis EF, Granger CB, K\u00f8ber L, Maggioni AP, Mann DL, McMurray J, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East C, Fernandez A, Jering K, Landmesser U, Mehran R, Merkely B, Vaghaiwalla Mody F, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Gong J, Braunwald E (2021) Angiotensin receptor-neprilysin inhibition in acute myocardial infarction. N Engl J Med 385:1845\u20131855","journal-title":"N Engl J Med"},{"key":"2398_CR23","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1002\/ehf2.14159","volume":"9","author":"A Bellis","year":"2022","unstructured":"Bellis A, Mauro C, Barbato E, Trimarco B, Morisco C (2022) The PARADISE-MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI. ESC Heart Failure 9:3698\u20133701","journal-title":"ESC Heart Failure"},{"key":"2398_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65:1231\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"2398_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.tcm.2022.03.001","volume":"33","author":"M Kumar","year":"2023","unstructured":"Kumar M, Thompson PD, Chen K (2023) New perspective on pathophysiology and management of functional mitral regurgitation. Trends Cardiovasc Med 33:386\u2013392","journal-title":"Trends Cardiovasc Med"},{"key":"2398_CR26","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1093\/eurheartj\/ehq411","volume":"31","author":"LA Pi\u00e9rard","year":"2010","unstructured":"Pi\u00e9rard LA, Carabello BA (2010) Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 31:2996\u20133005","journal-title":"Eur Heart J"},{"key":"2398_CR27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00059-015-4309-0","volume":"40","author":"B Peng","year":"2015","unstructured":"Peng B, Xia H, Ni A, Wu G, Jiang X (2015) Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention. Herz 40:898\u2013905","journal-title":"Herz"},{"key":"2398_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/cdt-21-386","volume":"12","author":"Y Dong","year":"2022","unstructured":"Dong Y, Xu Y, Ding C, Yu Z, Yu Z, Xia X, Chen Y, Jiang X (2022) Comparing the efficacy of angiotensin receptor-neprilysin inhibitor and enalapril in acute anterior STEMI patients after primary percutaneous coronary intervention: a prospective randomized trial. Cardiovasc Diagn Ther 12:42\u201354","journal-title":"Cardiovasc Diagn Ther"},{"key":"2398_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers SA, Brown NJ (2016) Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation 133:1115\u20131124","journal-title":"Circulation"},{"key":"2398_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ejhf.474","volume":"18","author":"Y Suematsu","year":"2016","unstructured":"Suematsu Y, Miura S, Goto M, Matsuo Y, Arimura T, Kuwano T, Imaizumi S, Iwata A, Yahiro E, Saku K (2016) LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. Eur J Heart Fail 18:386\u2013393","journal-title":"Eur J Heart Fail"},{"key":"2398_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","volume":"73","author":"MR Zile","year":"2019","unstructured":"Zile MR, O\u2019Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray J, Shi V, Lefkowitz M, Rouleau J (2019) Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF. J Am Coll Cardiol 73:795\u2013806","journal-title":"J Am Coll Cardiol"},{"key":"2398_CR32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"2398_CR33","first-page":"157","volume":"23","author":"AP Maggioni","year":"2022","unstructured":"Maggioni AP (2022) PARADISE-MI: another example why the results of a trial should not be considered as those of a soccer game. G Ital Cardiol (Rome) 23:157\u2013159","journal-title":"G Ital Cardiol (Rome)"},{"key":"2398_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/eurheartj\/ehab861","volume":"43","author":"G Liuzzo","year":"2022","unstructured":"Liuzzo G, Volpe M (2022) PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction. Eur Heart J 43:559\u2013560","journal-title":"Eur Heart J"},{"key":"2398_CR35","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.120.047643","volume":"142","author":"FR Mc Causland","year":"2020","unstructured":"Mc Causland FR, Lefkowitz MP, Claggett B, Anavekar NS, Senni M, Gori M, Jhund PS, McGrath MM, Packer M, Shi V, Van Veldhuisen DJ, Zannad F, Comin-Colet J, Pfeffer MA, McMurray J, Solomon SD (2020) Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction. Circulation 142:1236\u20131245","journal-title":"Circulation"},{"key":"2398_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","volume":"6","author":"K Damman","year":"2018","unstructured":"Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray J (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC Heart Fail 6:489\u2013498","journal-title":"JACC Heart Fail"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02398-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T19:02:02Z","timestamp":1721588522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02398-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02398-2","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"22 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}